In the adjacent non-neoplastic epithelium, there was a significant difference in the frequency of CDKN2A gene variants among the three groups for both ESCC (p = 0.032) and ESCN patients (p = 0.007); these values were the highest in the F-UR group. The gene discussed is CDKN2A; the disease is esophageal squamous cell carcinoma.